We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CXAI:NASDAQCXApp Inc. Analysis

Data as of 2026-03-28 - not real-time

$0.19

Latest Price

8/10Risk

Risk Level: High

Executive Summary

CXApp Inc. (CXAI) is trading at $0.19, well below its 20‑day SMA of $0.23 and 50‑day SMA of $0.24, indicating a bearish price position. The MACD histogram is negative and the signal line is labeled “bearish,” while the RSI sits at 42, suggesting limited upside momentum. Volatility is extreme at 139% over the past 30 days and the 30‑day max drawdown exceeds 88%, underscoring a highly unstable price environment. Fundamentals are weak: the company reports negative earnings per share, a trailing PE of 0, operating margins of –3.4%, and a cash balance that is eclipsed by $6.86 M of debt, yielding a debt‑to‑equity of 45%. Recent news highlights product launches and a new spatial‑intelligence layer, yet the firm has just received a 180‑day Nasdaq extension to regain the $1 minimum bid price, reflecting ongoing compliance pressure. Liquidity is eroding, with a decreasing volume trend despite a modest average daily volume relative to its $9 M market cap.
Given the confluence of bearish technical signals, severe financial strain, and regulatory headwinds, short‑term prospects appear dim, while any long‑term upside would depend on a successful turnaround of its AI‑driven workplace platform and a restoration of price compliance.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish technical indicators (price below SMAs, MACD bearish)
  • Nasdaq compliance extension indicating price pressure
  • Negative earnings and high cash burn

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential revenue upside from new AI workplace products
  • Continued cash‑flow deficits and debt load
  • Elevated volatility and liquidity concerns

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Significant upside potential if turnaround succeeds
  • Persistent structural financial weakness
  • Regulatory compliance risk remains until price exceeds $1

Key Metrics & Analysis

Financial Health

Revenue Growth-41.30%
Profit Margin-215.40%
P/E Ratio-0.3
ROE-76.23%
ROA-30.15%
Debt/Equity45.04
P/B Ratio0.3
Op. Cash Flow$-9446000
Free Cash Flow$-7218375
Industry P/E32.0

Technical Analysis

TrendBearish
RSI41.9
Support$0.16
Resistance$0.32
MA 20$0.23
MA 50$0.24
MA 200$0.60
MACDBearish
VolumeDecreasing
Fear & Greed Index65.98

Valuation

Target Price$2.00
Upside/Downside929.34%
GradeUndervalued
TypeValue

Risk Assessment

Beta-0.18
Volatility139.31%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.